Ligand Pharmaceuticals – Board Diversity (2019) — Issue Type =
Outcome: Successfully withdrawn following the company’s commitment to strengthen its governance policies by adopting a policy of inclusiveness such that the nominating and corporate governance committee considers diversity of age, gender, race, ethnicity, international experience and other specialized experience in each director candidate search.